Rui Avelar
Chief Tech/Sci/R&D Officer chez EVOLUS, INC.
Fortune : 5 M $ au 31/03/2024
Profil
Rui Avelar is currently the Chief Medical Officer, Head-Research & Development at Evolus, Inc. He previously held the position of Chief Medical Officer at Allergan Medical Optics from 2011 to 2013 and at AEON Biopharma Sub, Inc. from 2014 to 2018.
Dr. Avelar obtained his doctorate degree from the University of Toronto in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOLUS, INC.
0,61% | 19/03/2024 | 372 288 ( 0,61% ) | 5 M $ | 31/03/2024 |
Postes actifs de Rui Avelar
| Sociétés | Poste | Début |
|---|---|---|
| EVOLUS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Anciens postes connus de Rui Avelar
| Sociétés | Poste | Fin |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Chief Tech/Sci/R&D Officer | 01/02/2018 |
| Allergan Medical Optics | Chief Tech/Sci/R&D Officer | 01/12/2013 |
Formation de Rui Avelar
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EVOLUS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Allergan Medical Optics | |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
